PURPOSE: To prospectively evaluate the association of vitamin/mineral supplementation with cancer, cardiovascular, and all-cause mortality. METHODS: In the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg), which was recruited in 1994-1998, 23,943 participants without pre-existing cancer and myocardial infarction/stroke at baseline were included in the analyses. Vitamin/mineral supplementation was assessed at baseline and during follow-up. Cox regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). RESULTS: After an average follow-up time of 11 years, 1,101 deaths were documented (cancer deaths = 513 and cardiovascular deaths = 264). After adjustment for potential confounders, neither any vitamin/mineral supplementation nor multivitamin supplementation at baseline was statistically significantly associated with cancer, cardiovascular, or all-cause mortality. However, baseline users of antioxidant vitamin supplements had a significantly reduced risk of cancer mortality (HR: 0.52; 95% CI: 0.28, 0.97) and all-cause mortality (HR: 0.58; 95% CI: 0.38, 0.88). In comparison with never users, baseline non-users who started taking vitamin/mineral supplements during follow-up had significantly increased risks of cancer mortality (HR: 1.74; 95% CI: 1.09, 2.77) and all-cause mortality (HR: 1.58; 95% CI: 1.17, 2.14). CONCLUSIONS: Based on limited numbers of users and cases, this cohort study suggests that supplementation of antioxidant vitamins might possibly reduce cancer and all-cause mortality. The significantly increased risks of cancer and all-cause mortality among baseline non-users who started taking supplements during follow-up may suggest a "sick-user effect," which researchers should be cautious of in future observational studies.
PURPOSE: To prospectively evaluate the association of vitamin/mineral supplementation with cancer, cardiovascular, and all-cause mortality. METHODS: In the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg), which was recruited in 1994-1998, 23,943 participants without pre-existing cancer and myocardial infarction/stroke at baseline were included in the analyses. Vitamin/mineral supplementation was assessed at baseline and during follow-up. Cox regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). RESULTS: After an average follow-up time of 11 years, 1,101 deaths were documented (cancer deaths = 513 and cardiovascular deaths = 264). After adjustment for potential confounders, neither any vitamin/mineral supplementation nor multivitamin supplementation at baseline was statistically significantly associated with cancer, cardiovascular, or all-cause mortality. However, baseline users of antioxidant vitamin supplements had a significantly reduced risk of cancer mortality (HR: 0.52; 95% CI: 0.28, 0.97) and all-cause mortality (HR: 0.58; 95% CI: 0.38, 0.88). In comparison with never users, baseline non-users who started taking vitamin/mineral supplements during follow-up had significantly increased risks of cancer mortality (HR: 1.74; 95% CI: 1.09, 2.77) and all-cause mortality (HR: 1.58; 95% CI: 1.17, 2.14). CONCLUSIONS: Based on limited numbers of users and cases, this cohort study suggests that supplementation of antioxidant vitamins might possibly reduce cancer and all-cause mortality. The significantly increased risks of cancer and all-cause mortality among baseline non-users who started taking supplements during follow-up may suggest a "sick-user effect," which researchers should be cautious of in future observational studies.
Authors: Aditya Bardia; Imad M Tleyjeh; James R Cerhan; Amit K Sood; Paul J Limburg; Patricia J Erwin; Victor M Montori Journal: Mayo Clin Proc Date: 2008-01 Impact factor: 7.616
Authors: Marian L Neuhouser; Sylvia Wassertheil-Smoller; Cynthia Thomson; Aaron Aragaki; Garnet L Anderson; JoAnn E Manson; Ruth E Patterson; Thomas E Rohan; Linda van Horn; James M Shikany; Asha Thomas; Andrea LaCroix; Ross L Prentice Journal: Arch Intern Med Date: 2009-02-09
Authors: Melissa Farmer Miller; Keith M Bellizzi; Meryl Sufian; Anita H Ambs; Michael S Goldstein; Rachel Ballard-Barbash Journal: J Am Diet Assoc Date: 2008-03
Authors: J Michael Gaziano; Howard D Sesso; William G Christen; Vadim Bubes; Joanne P Smith; Jean MacFadyen; Miriam Schvartz; JoAnn E Manson; Robert J Glynn; Julie E Buring Journal: JAMA Date: 2012-11-14 Impact factor: 56.272
Authors: Pamela M Rist; Howard D Sesso; Lisa G Johnson; Aaron K Aragaki; Lu Wang; Susanne Rautiainen; Aditi Hazra; Deirdre K Tobias; Meryl S LeBoff; Hagen Schroeter; Georgina Friedenberg; Trisha Copeland; Allison Clar; Lesley F Tinker; Rebecca P Hunt; Shari S Bassuk; Ara Sarkissian; Douglas C Smith; Eduardo Pereira; William R Carrick; Emily S Wion; Jennifer Schoenberg; Garnet L Anderson; JoAnn E Manson Journal: Contemp Clin Trials Date: 2022-03-12 Impact factor: 2.261